News

The Mediterranean diet, high in plants and low on meat and dairy, has been linked to a host of health benefits – including ...
Fatty liver disease is a growing epidemic, but it’s one where early detection and dietary interventions offer a hopeful path ...
Objective Non-alcoholic fatty liver disease (NAFLD) is the leading cause of end-stage liver diseases worldwide. Understanding NAFLD prevalence and trends over time at the global, regional and national ...
Non-alcoholic fatty liver disease (NAFLD) is common, affecting approximately 25% of the general population. The evidence base for the investigation and management of NAFLD is large and growing, but ...
Beetroot, a nutritional powerhouse packed with antioxidants, betaine, and nitrates, is emerging as a champion for liver health. Studies suggest beetroot juice can combat fatty liver disease by ...
SAN FRANCISCO, Calif. — June 13, 2025 — Vial, a clinical-stage biotechnology company, announced that it has initiated the Phase 1 trial for a novel, subcutaneous, half-life extended monoclonal ...
Karl's experience demonstrates that fatty liver disease can remain stable for extended periods with proper monitoring and care. His case shows the importance of early detection and consistent medical ...
By Dennis Thompson HealthDay ReporterFRIDAY, June 6, 2025 (HealthDay News) — A repurposed diabetes drug can be an effective tool against fatty liver disease, a new clinical trial has found.
The projected yearly incidence of hospitalized patients with chronic liver disease also increased during this time — from 2,288,242 in 2018 to 2,754,542 in 2023.
Current and target pathways to a MASH diagnosis. Abbreviations: MASH, metabolic dysfunction-associated steatohepatitis. Credit: The Lancet Regional Health - Europe (2025). DOI: 10.1016/j.lanepe ...
Liver disease accounts for two million deaths annually. This is 4% of all deaths (1 out of every 25 deaths worldwide), as per the data from 2023. Liver disease is a growing global health concern.